Skip to main content

Media Category: x - EACCME

Part 5/5 on Microglia: Role of microglia in neuroprotection and remyelination processes in MS (Accredited by EACCME)

Navigate to this page to start this elearning. This e-learning module is part of a series of 5 e-learnings created by ParadigMS on Microglia as a target for the treatment of MS. Each module has a lead author and several contributors, all are neurologists with an expertise in multiple sclerosis and members of ParadigMS. You will receive an EACCME certificate upon completing the e-learning and successfully passing an exam.

Continue reading

Part 4/5 on Microglia: Microglia as a target for the treatment of MS (Accredited by EACCME)

Navigate to this page to start this elearning. This e-learning module is part of a series of 5 e-learnings created by ParadigMS on Microglia as a target for the treatment of MS. Each module has a lead author and several contributors, all are neurologists with an expertise in multiple sclerosis and members of ParadigMS. You will receive an EACCME certificate upon completing the e-learning and successfully passing an exam.

Continue reading

Risks, pregnancy and vaccination in MS (Accredited by EACCME)

Navigate to this page to start this elearning. The e-learning on ‘Risks, pregnancy, vaccination and MS’ includes engaging case-based examples given by experts in the field of MS. This e-learning is accredited via EACCME. You will receive a certificate for 1 European CME credit upon watching the webinar in full and successfully completing an exam. Your will be able to download your certificate upon completion of the exam.

Continue reading

Part 2/5 on Microglia: Clinical progression and the relation with innate immune cells (Accredited by EACCME)

Navigate to this page to start this elearning. This e-learning module is part of a series of 5 e-learnings created by ParadigMS on Microglia as a clinical progression and the relation with innate immune cells. Each module has a lead author and several contributors, all are neurologists with an expertise in multiple sclerosis and members of ParadigMS. You will receive an EACCME certificate upon completing the e-learning and successfully passing an exam.

Continue reading

Prognostication, high efficacy treatments and virtual care in multiple sclerosis (Accredited by EACCME)

Navigate to this page to start this elearning. This e-learning module is part of a series of 5 e-learnings created by ParadigMS on Prognostication, high efficacy treatments and virtual care in MS. Each module has a lead author and several contributors, all are neurologists with an expertise in multiple sclerosis and members of ParadigMS. You will receive an EACCME certificate upon completing the e-learning and successfully passing an exam.

Continue reading

Part 1/5 on Microglia: Innate immune system in the central nervous system (Accredited by EACCME)

Navigate to this page to start this elearning. This e-learning module is part of a series of 5 e-learnings created by ParadigMS on ‘the role of Microglia in Multiple Sclerosis’. Each module has a lead author and several contributors, all are neurologists with an expertise in multiple sclerosis and members of ParadigMS. You will receive an EACCME certificate upon completing the e-learning and successfully passing an exam.

Continue reading

FAQs

Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.